InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-1.2%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Multani Pratik S, 董事. Insider active across 3 companies, notably Erasca, Inc.. Cumulatively, 8 reports have been logged. Split: 1 buy · 1 sell. Total volume traded: €91k. History available since 20 July 2021. The latest transaction was disclosed on 15 December 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Multani Pratik S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
29,333 股0Common StockSEC:0001586894-25-000005:0
6,200 股0Common StockSEC:0000950170-25-080941:0
24,042 股0Common StockSEC:0001415889-24-029633:0
14,042 股0Common StockSEC:0001209191-23-059266:0
2,227 股@ US$3.0739100.0% 占其流量Common StockSEC:0001209191-23-010616:0
6,041 股0Common StockSEC:0001209191-22-061756:0
6,200 股@ US$16.00100.0% 占其流量Common StockSEC:0000899243-21-029060:0
标准退出：2021年10月18日 (T+90)
26,400 股Common StockSEC:0001209191-16-090817:0
8 条申报中的 8 条
About Multani Pratik S
Multani Pratik S is Administrateur. He has 8 filings in total. Among the recent filings available, the reported volumes are EUR 84,181 of buys and EUR 6,412 of sells, between 2016-01-11 and 2025-12-17, and the most common transaction nature is Option exercise. He is linked to Oric Pharmaceuticals, Inc. as Chief Medical Officer, to Erasca, Inc. as Director, and to Ignyta, Inc. as Chief Medical Officer.
